March 25, 2022 01:39 PM EDT
Pharma
Marketing

Mo­bile apps for IBS? In­de­gene teams with metaMe to launch 'gut-di­rect­ed hyp­nother­a­py' dig­i­tal ther­a­peu­tic

Beth Snyder Bulik

Senior Editor

What if in­stead of tak­ing a pill or in­jec­tion, you could down­load an app to help ease the pain of ir­ri­ta­ble bow­el syn­drome?

That’s what …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

A service from the Financial Times